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ABSTRACT: Type of study: Prevalence study.
Objectives: Despite pityriasis lichenoides is an uncommon dermatosis, we observed 12 cases
in the last 3 years. By this means, we review clinical and histopathologic findings of all patients
with pityriasis lichenoides seen at our Division. Furthermore, since pathogenic features of the
disease are unknown, we performed HLA class I and II typings to search for possible immunogenetic
markers for pityriasis lichenoides.
Methods: Twenty-one patients with biopsy-proven diagnosis of pityriasis lichenoides were
evaluated. HLA class I and II antigens were typed using conventional serological procedures.
Results: Children and young adults were predominantly affected. Most of the cases were seen
in fall and winter time. Typical disseminated lesions were observed more frequently. Both acute
and chronic patterns were observed at histology. Compared to controls, the HLA-B17 antigen was
overrepresented in patients (P < 0.005).
Conclusions: Although pityriasis lichenoides remains a cutaneous disease of undetermined
origin, our findings show that the disease is associated with the HLA-B17 antigen.
UNITERMS: Pityriasis Lichenoides. HLA Antigens. Histology. Immunogenetics.
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1. INTRODUCTION
Pityriasis lichenoides (PL) is an uncommon
self-limited dermatosis which occurs at any age,
particularly in children and young adults(1,2,3). Two
variants of the disease are described: a mild chronic
form referred to as pityriasis lichenoides chronica
(PLC), and an acute form also known as pityriasis
lichenoides et varioliformis acuta (PLEVA)(2). Despite
the treatment with antimicrobials are somewhat
beneficial, etiopathogenic mechanisms have not been
elucidated. Immune complexes, cell-mediated
immunity and endothelial cells bearing HLA class II
antigens have been implicated in  the pathogenesis of
the disease(4/8). Immunogenetic studies on the
susceptibility to this dermatosis  have never been
accomplished. In this study, besides clinical and
laboratory evaluation of, we typed HLA class I and II
antigens in a series of patients presenting with pityriasis
lichenoides.
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2. MATERIAL AND METHODS
2.1. Patients
A total of 21 patients seen at the University
Hospital of the Faculty of Medicine of Ribeirão Preto,
São Paulo, Brazil, from 1978 to 1993, were retrospec-
tively studied. The men to women ratio was 1.6, with
ages varying from 10  to  60 years (median 20). Diag-
nosis of pityriasis lichenoides was performed on the
basis of clinical and histopathological features.
2.2. Controls
A total of  100 blood donors from same geo-
graphical area and presumably of similar ethnic back-
ground were also typed for HLA antigens.
2.3. HLA antigens
 Mononuclear peripheral cells were isolated us-
ing Ficoll-Hypaque gradient at a density of 1.077 g/l.
B lymphocytes were obtained by adherence to nylon
wool. HLA typing was performed by a  microlympho-
cytotoxicity assay(9), using commercially available
antisera (Pel Freez, Gen Track-USA; Biotest-Ger-
many). A total of 72 HLA class I (A, B) and class II
(DR.DQ) specificities were used. Complement was
obtained from a pool of normal rabbit sera.
2.4. Statistical analysis
Comparisons of HLA frequency between pa-
tients and controls was performed using the bicaudal
Fisher exact test, correcting the P value according to
the number of HLA specificities. Differences were con-
sidered significant at P < 0.05. The  relative risk (RR)
which indicates how many times more often the
disease occurs in individuals with the HLA antigen
compared to those without it, and the etiologic fraction
(EF) which defines the attributable risk at the popula-
tion level were also calculated (10).
3. RESULTS
Most of the cases was observed among chil-
dren and young adults (Figure 1). More than 79% of
the cases occurred in Brazilian fall and winter sea-
sons (April to June and July to September, respec-
tively). With regard to distribution of cutaneous lesions,
71% of patients presented typical lesions disseminated
along the whole body, whereas 19% presented with
lesions restricted to the trunk, neck, and  proximal as-
pects of extremities. Only 10% of patients presented
peripheral lesions confined to upper and lower limbs.
Fever preceded cutaneous lesions in 14% of patients,
and pruritus was seen along with lesions in 76% of
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Figure 1: Bimodal distribution of pityriasis lichenoides cases according to age (years) from 1978 to 1993. Sex distribution is also
shown.
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patients. Hypopigmented macules were
observed in 48% even on the first cuta-
neous examination. Both erythematous
papules with central scales (affecting
also the scalp) and mucous membranes
involvement were seen in 14% of cases,
respectively. Adenomegaly was observed
in 38% of patients. Nineteen percent of
patients had both lesions of PLEVA and
PLC, however, histological  features of
typical PLEVA or PLC were observed in
33% and 44% of the cases, respectively.
HLA typing was performed in only
14 patients. The frequency of HLA-B17
antigen in patients was 36% whereas in
control individuals this antigen was ob-
served only in 1% (Figure 2).
The comparison of the frequency of HLA-B17
antigen in patients was significantly increased when
compared to controls (P = 0,005). The HLA-B17 anti-
gen conferred an RR of 55 and an EF of 35. The fre-
quency of HLA class I and II antigens is shown in
(Table I), where the comparisons of HLA class I or II
antigens between patients and controls disclosed no
significant differences.
Figure 2: Relative frequency of HLA-B17 in patients and controls in comparison
with other HLA-B antigens.
4. DISCUSSION
The clinical and laboratory features presented
by the patients of this series were similar  to those re-
ported by other authors(1,2,3), emphasizing the predomi-
nance of the disease in children and young adults, and
the occurrence of the disease predominantly in fall and
winter time.
Table I - Frequency (%) of HLA class I (A and B) and class II (DR and DQ) antigens in patients presenting
with pityriasis lichenoides (n = 14) and controls (n = 100). Frequencies observed in controls are shown in
parenthesis. Although 72 specificities were tested, only those seen in patients are shown
HLA-A % HLA-B % HLA-DR % HLA-DQ %
P C P C P C P C
A1
A2
A3
A9
A10
A11
A28
A30
A33
7
7
7
7
14
21
21
40
42
(21)
(46)
(12)
(27)
(27)
(16)
(10)
(4)
(2)
B7
B15
B17
B44
B49
B51
B60
21
7
36
36
7
21
7
(14)
(2)
(1)*
(16)
(6)
(14)
(6)
DR1
DR2
DR3
DR4
DR6
DR7
DR9
DR11
36
28
50
21
7
28
14
14
(26)
(31)
(28)
(23)
(6)
(21)
(2)
(12)
DQ1
DQ2
DQ3
DQ7
78
21
57
36
(64)
(40)
(44)
(37)
* HLA-B17  corrected P value < 0.005,    relative risk = 55,    etiologic fraction = 35.
P = patients C= controls
HLA-B17 P
HLA-B17 C
Other HLA
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RESUMO: Modelo de estudo: Estudo de prevalência.
Objetivos: Embora a pitiríase liquenóide seja uma dermatose incomum, 12 casos foram por
nós observados nos últimos três anos. Assim, neste estudo, avaliamos os perfis clínicos e histo-
patológicos dos pacientes com pitiríase liquenóide, atendidos na Divisão de Dermatologia. Além
disso, tipificamos os antígenos HLA de classes I e II nesses pacientes.
Metodologia: Foram estudados 21 pacientes com diagnóstico clínico e histopatológico de
pitiríase liquenóide. As tipificações dos antígenos de histocompatibilidade de classes I e II foram
realizadas, utilizando-se métodos sorológicos.
Resultados: A maioria dos casos ocorreu entre  crianças e ou adultos jovens, no outono e
inverno. As lesões típicas de forma disseminada foram as mais freqüentes. Os achados histo-
patológicos mostraram lesões dos tipos agudo e crônico. O antígeno HLA-B17 estava
significantemente aumentado nos pacientes em relação aos controles (P < 0,005).
Conclusões: Embora a etiologia da pitiríase liquenóide não seja conhecida, os achados aqui
relatados mostram que o marcador HLA-B17 é prevalente entre os doentes.
UNITERMOS: Pitiríase Liquenóide . Antígenos HLA. Histologia. Imunogenética.
Compared to controls, the class I HLA-B17 an-
tigen was overrepresented in patients presenting with
pityriasis lichenoides, conferring high RR and E.F. The
most striking association of a HLA class I antigen with
a disease is the observation that HLA-B27+ Caucasian
individuals have 91 times the risk of developing
ankylosing spondylitis than HLA-B27— individuals(11).
Besides ankylosing spondylitis, HLA-B27 antigen has
also been associated with Reiter’s syndrome and acute
anterior uveitis. Particularly, Reiter’s syndrome encom-
passes a reactive arthritis seen after episodes of infec-
tion caused by several enteric and/or urogenital patho-
gens such as Shigella, Salmonella, Yersinia,
Campylobacter, Chlamydia and Ureaplasma(12). One
of the mechanisms of HLA class I molecule associa-
tion with disease is the mimicry between certain
epitopes of the causative agents with those of HLA
molecules(13). Corroborating this hypothesis is the ob-
servation of a stretch of 5 amminoacid residues shared
by Shigella strain plasmids and the HLA-B27 mol-
ecule(12,13). Although an infectious agent has not been
implicated in the pathogenesis of pityriasis lichenoides,
the involution of cutaneous lesions following an anti-
biotic treatment suggest the participation of an infec-
tious pathogen. Paralelling the hypotheses which have
been proposed to explain the pathogenesis of Reiter’s
syndrome, when susceptible individuals carrying the
HLA-B17 antigen upon  contact with an yet undeter-
mined environmental agent  may trigger the develop-
ment of pityriasis lichenoides.
Increased diffuse expression of HLA-DR
molecules have been reported on the cell surface of
epidermal keratinocytes of patients presenting with
pityriasis lichenoides(4/8), suggesting the participation
of cells bearing HLA class II molecules in the patho-
genesis of the disease. However, the comparisons of
the frequency of  HLA-DR and HLA-DQ antigens
between patients and controls revealed no significant
differences. Although we were not able to define a
specific association between HLA class II antigen
with pityriasis lichenoides, an association with HLA
class II specificities cannot be ruled out. In this study,
only serologically defined specificities were tested, per-
haps the utilization of more discriminative methods such
as the molecular ones may disclose such an
association.
In conclusion, few reports have focused on the
study of the immunopathogenic  events which are go-
ing on pityriasis lichenoides, and much has to be learned
about them. Notwithstanding, the findings reported here
showed  that an HLA class I antigen is overrepresented
in patients. presenting with pityriasis lichenoides, and
indicate that the HLA-B17 antigen as a susceptible
marker for the development of the disease.
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